Flow Cytometry-based Biomarkers in Translational Medicine and Drug Development
Title | Flow Cytometry-based Biomarkers in Translational Medicine and Drug Development PDF eBook |
Author | Virginia Litwin |
Publisher | |
Pages | 261 |
Release | 2011 |
Genre | |
ISBN |
Flow Cytometry in Drug Discovery and Development
Title | Flow Cytometry in Drug Discovery and Development PDF eBook |
Author | Virginia Litwin |
Publisher | Wiley |
Pages | 0 |
Release | 2011-01-11 |
Genre | Medical |
ISBN | 9780470433560 |
This book covers the unique application of flow cytometry in drug discovery and development. The first section includes two introductory chapters, one on flow cytometry and one on biomarkers, as well as a chapter on recent advances in flow cytometry. The second section focuses on the unique challenges and added benefits associated with the use of flow cytometry in the drug development process. The third section contains a single chapter presenting an in depth discussion of validation considerations and regulatory compliance issues associated with drug development.
Biomarkers in Drug Development
Title | Biomarkers in Drug Development PDF eBook |
Author | Michael R. Bleavins |
Publisher | John Wiley & Sons |
Pages | 559 |
Release | 2011-09-20 |
Genre | Medical |
ISBN | 1118210425 |
Discover how biomarkers can boost the success rate of drug development efforts As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of the drug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine. Biomarkers in Drug Development is divided into eight parts: Part One offers an overview of biomarkers and their role in drug development. Part Two highlights important technologies to help researchers identify new biomarkers. Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose. Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine. Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs. Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns. Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development.
Translating Molecular Biomarkers into Clinical Assays
Title | Translating Molecular Biomarkers into Clinical Assays PDF eBook |
Author | Russell Weiner |
Publisher | Springer |
Pages | 217 |
Release | 2016-08-22 |
Genre | Medical |
ISBN | 3319407937 |
This handbook covers established and advanced techniques for biomarker analysis, such as guidelines and strategies for assay validation methods; different mathematical models that are necessary in contemporary drug discovery and development; and evaluation of new cytometry methods. Expertly curated by two practicing professionals in drug development and biotherapeutics, individual chapters are selected for novel and sound research; information is chosen based on its relevance to lab applications and clinical trials, such as the topic of selecting animal models for their relevancy to humans. The book is multifaceted, discussing the ethics and issues with biospecimens and providing an in-depth analysis to the differences between pre-clinical and clinical assay development. The book is an essential read for general readers who need an introduction to the history and background of biomarkers, and it also provides critical analyses of various new validation methods for practitioners and researchers.
Handbook of Biomarkers and Precision Medicine
Title | Handbook of Biomarkers and Precision Medicine PDF eBook |
Author | Claudio Carini |
Publisher | CRC Press |
Pages | 631 |
Release | 2019-04-16 |
Genre | Mathematics |
ISBN | 0429576730 |
"The field of Biomarkers and Precision Medicine in drug development is rapidly evolving and this book presents a snapshot of exciting new approaches. By presenting a wide range of biomarker applications, discussed by knowledgeable and experienced scientists, readers will develop an appreciation of the scope and breadth of biomarker knowledge and find examples that will help them in their own work." -Maria Freire, Foundation for the National Institutes of Health Handbook of Biomarkers and Precision Medicine provides comprehensive insights into biomarker discovery and development which has driven the new era of Precision Medicine. A wide variety of renowned experts from government, academia, teaching hospitals, biotechnology and pharmaceutical companies share best practices, examples and exciting new developments. The handbook aims to provide in-depth knowledge to research scientists, students and decision makers engaged in Biomarker and Precision Medicine-centric drug development. Features: Detailed insights into biomarker discovery, validation and diagnostic development with implementation strategies Lessons-learned from successful Precision Medicine case studies A variety of exciting and emerging biomarker technologies The next frontiers and future challenges of biomarkers in Precision Medicine Claudio Carini, Mark Fidock and Alain van Gool are internationally recognized as scientific leaders in Biomarkers and Precision Medicine. They have worked for decades in academia and pharmaceutical industry in EU, USA and Asia. Currently, Dr. Carini is Honorary Faculty at Kings’s College School of Medicine, London, UK. Dr. Fidock is Vice President of Precision Medicine Laboratories at AstraZeneca, Cambridge, UK. Prof.dr. van Gool is Head Translational Metabolic Laboratory at Radboud university medical school, Nijmegen, NL.
Accelerating the Development of Biomarkers for Drug Safety
Title | Accelerating the Development of Biomarkers for Drug Safety PDF eBook |
Author | Institute of Medicine |
Publisher | National Academies Press |
Pages | 101 |
Release | 2009-07-20 |
Genre | Medical |
ISBN | 0309142318 |
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.
Assessment of Cell Cycle Inhibitors by Flow Cytometry
Title | Assessment of Cell Cycle Inhibitors by Flow Cytometry PDF eBook |
Author | Paolo Cappella |
Publisher | |
Pages | |
Release | 2011 |
Genre | |
ISBN | 9789533076157 |